Author Guidelines

• Official Templates: Manuscripts must strictly follow the official formatting templates:
• • Full Paper Template (4+1 pages)
  • 1-Page Abstract Template
• Page Limits: Submissions are subject to a strict 5-page limit:
  • Pages 1–4: Technical text, figures, tables, and equations.
  • Page 5: Strictly reserved for acknowledgments and references only. No core technical content may appear on this page.
• Reference Limit: References must not exceed 20 citations.
• Originality: Submissions must describe original, unpublished work and cannot be under review elsewhere.
• Author Cap: Each manuscript may list a maximum of 35 authors.
• Language: All papers must be written in English.
• Policy Adherence: All Papers submitted to EMBC must:
  • Be compliant with the IEEE Publications Service and Products Board Operations Manual and all policies therein
  • Be compliant with the IEEE Engineering in Medicine and Biology Society Code of Ethics

Non-compliant submissions, including papers exceeding length constraints or altering template margins/fonts, will be desk-rejected without review.

Building upon the IEEE Guidelines on AI-Generated Content, EMBC 2027 institutes several key extensions:

• Mandatory Disclosure: Any content generated by artificial intelligence tools (including but not limited to text, figures, images, or code) must be explicitly disclosed in the Acknowledgments Authors must:
  1. Name the specific AI tool/model used.
  2. Identify the sections where the AI-generated material appears.
  3. Provide a brief explanation describing the scope and level of AI assistance.
• Editing and Grammar Tools: Standard use of AI-assisted spelling, grammar, and phrasing enhancers (e.g., Grammarly) does not require mandatory disclosure, though disclosure remains encouraged for transparency.
• Grounds for Rejection: Unacknowledged use of generative AI, including the presence of fabricated/hallucinated citations, synthetic data, or misleading graphics, constitutes academic misconduct and will result in immediate rejection.
• Prompt Injection: Any attempt to manipulate LLM-based editorial or review pipelines via hidden prompts, white-text injections, or adversarial instructions will result in an immediate desk rejection and referral for ethics review.
• Reference Material: For further details, please refer to the video tutorial on IEEE’s policy regarding the use of content generated by AI.

To support peer review capacity and maintain high evaluative standards, every submitted paper must register at least one qualified co-author committed to reviewing submissions for EMBC 2027.

Reviewer Qualifications

The designated reciprocal reviewer must meet the following baseline criteria:

• Possess research experience equivalent to or exceeding that of a second-year graduate student in an EMBC-relevant themes.
• Have served as a primary (first or corresponding) author on at least two peer-reviewed papers published in related IEEE or biomedical engineering venues (e.g., EMBC, BHI, BSN, NER, BNM, ISBI, TBME, JBHI, TNSRE, J-TEHM, OJ-EMB, RBME, TMI, TNB, TMRB, or equivalent).
• First-Time Reviewers: First-time reviewers are strongly encouraged to coordinate with an experienced research mentor or advisor to oversee and guide their reviews.

Workload Cap

An individual researcher may serve as the reciprocal reviewer for a maximum of two (2) submissions.

Exemption Criteria

A submission is exempt from the reciprocal review requirement only if:

• None of the co-authors meet the qualification criteria outlined above; or
• All qualified co-authors have already reached their limit of two reciprocal review assignments, or are currently serving in primary organizing roles for EMBC 2027 (e.g., Theme Editors, Associate Editors, Organizing Committee).

Enforcement and Declarations 

Submitters must either assign their designated reviewer or declare an exemption via the submission portal.

• Falsified Exemptions: Inaccurate or deceptive exemption claims will result in immediate desk rejection.
• Review Delinquency: Reciprocal reviewers who fail to participate meaningfully (e.g., unsubmitted reviews, missed deadlines, superficial reviews, or AI-generated reviews) risk having their own submitted papers desk-rejected or withdrawn.

EMBC 2027 welcomes submissions spanning the full breadth of biomedical engineering. Directly reflecting the EMBS Technical Communities, the themes listed below outline the scope of the conference. Each submission must be mapped to the most applicable theme.

• Biomedical Signal Processing
• Biomedical Imaging and Image Processing
• Bionanotechnology and BioMEMS
• Cardiopulmonary Systems and Physiology-based Engineering
• Neural and Rehabilitation Engineering
• Wearable Biomedical Sensors and Systems
• Biorobotics and Biomechanics
• Therapeutic & Diagnostic Systems and Technologies
• Biomedical & Health Informatics
• Biomedical Engineering Education and Society
• Biomedical Engineering Translation

Policy

• EMBS enforces a no-show policy. Any paper that is accepted to the conference, completes final submission, and is included in the final program must be presented at the conference.
• The corresponding author is the scheduled presenter of the paper, and is required to present the paper at the scheduled presentation date and time determined by the conference organizing committee.
• The author(s) of any paper that is added to the final conference program but is not presented as scheduled will be subscribed to the no-show list compiled by EMBS.

EMBS No Show Author List

• Authors who are listed on the EMBS no-show list will be included on said list for a period of no less than 2 years.
• The list of no-shows will be made available to All EMBS Conference organizers, and said organizers may reject submissions from authors included on the no show list.

Substitutions

• Whereas the corresponding author is required to present the paper, should any circumstances arise where the corresponding author is unable to present the paper at the conference, the corresponding author may delegate the presentation responsibility to one of the listed co-authors of the paper to present the paper in his or her absence.
• Said substitution of a corresponding author by a co-author must be documented and substantiated in advance via the EMBS Substitute/Absentee Form.
• It is the responsibility of the corresponding author to submit a substitute/absentee case to the EMBS executive office before the scheduled date of the presentation.
• Undocumented Substitutions will be considered a corresponding author “no show”.
• Should a circumstance arise where none of the listed authors are able to present the paper at the conference it is the responsibility of the corresponding author to submit a substitute/absentee case to via the EMBS Substitute/Absentee Form documenting the reason for the absence.
• Cases submitted to the EMBS Substitute Absentee Form, where the paper is not presented by the corresponding author or a substitute co-authors will be reviewed on its merits, and supporting documentation may be required.

For details on post-publication policies, including the treatment of papers submitted to arXiv, please refer to the IEEE policy link below:

Important note: Plagiarism checks may produce high similarity scores for papers that have already been uploaded to arXiv, bioRxiv, or other preprint servers. This is acceptable, provided that, upon acceptance to EMBC, authors indicate that an updated version of the preprint has been accepted for publication at IEEE EMBC. Authors should also ensure that the version available on the preprint server is sufficiently differentiated from the final EMBC paper (for example, by modifying figures or content if it is substantially similar).

This approach is consistent with standard publishing practices. Our role is limited to advising authors of this requirement. Responsibility for updating or modifying the preprint after IEEE publication rests with the authors. Failure to do so may result in potential copyright issues under IEEE policies.